Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH).


Journal

Expert opinion on pharmacotherapy
ISSN: 1744-7666
Titre abrégé: Expert Opin Pharmacother
Pays: England
ID NLM: 100897346

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 27 2 2021
medline: 29 6 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

When coronavirus infectious disease-2019 (COVID-19) blew up, ill-fated auguries on the collision between COVID-19 and the human immunodeficiency virus (HIV) epidemics loomed. Data from observational studies suggest similar incidence attacks of SARS-CoV-2 infection in people living with HIV (PLWH) and HIV-uninfected populations. The mortality rate of COVID-19 is similar in both populations too. The authors discuss the role of combination antiretroviral therapy (cART) in preventing infection or reducing COVID-19 severity. They also discuss the pharmacological interventions for COVID-19 in PLWH. Management of COVID-19 in PLWH is no different from the general population. It should be based on careful supportive care, emphasizing lung-protective ventilation, and wise pharmacological interventions. The antiviral drug remdesivir and dexamethasone are the only pharmacological interventions with clinical benefit for COVID-19, whereas anticoagulation may prevent thrombotic complications. The experience with using these drugs in PLWH is limited, which prevents from rendering well-founded conclusions. Until more data on COVID-19 in PLWH become available, the best weapons within our reach are sound supportive care and sensible use of RDV and dexamethasone, bearing in mind the potential for drug-drug interactions of most corticosteroids and antiretroviral drugs.

Identifiants

pubmed: 33634724
doi: 10.1080/14656566.2021.1887140
pmc: PMC7919104
doi:

Substances chimiques

Anti-Retroviral Agents 0
Antiviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1127-1141

Références

Pharmacol Res. 2020 Aug;158:104898
pubmed: 32438034
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2003 Dec 24;290(24):3222-8
pubmed: 14693875
J Med Virol. 2020 Nov;92(11):2338-2340
pubmed: 32427361
J Med Virol. 2020 Nov;92(11):2387-2389
pubmed: 32462663
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
J Med Virol. 2020 Oct;92(10):1777-1778
pubmed: 32293709
Antiviral Res. 2020 Jun;178:104786
pubmed: 32251767
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Clin Pharmacol Ther. 2011 May;89(5):735-40
pubmed: 21430660
JAMA. 2020 Sep 15;324(11):1048-1057
pubmed: 32821939
Lancet Rheumatol. 2020 Dec;2(12):e754-e763
pubmed: 33015645
N Engl J Med. 2012 May 17;366(20):1881-90
pubmed: 22591294
Int J Infect Dis. 2021 Feb;103:1-2
pubmed: 33075529
BMJ. 2020 May 14;369:m1849
pubmed: 32409561
Int J Antimicrob Agents. 2020 Oct;56(4):106144
pubmed: 32853673
Eur J Intern Med. 2020 Dec;82:38-47
pubmed: 32859477
Int Immunopharmacol. 2020 Aug;85:106688
pubmed: 32544867
AIDS Patient Care STDS. 2020 Aug;34(8):331-335
pubmed: 32469614
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
Clin Infect Dis. 2020 Nov 19;71(16):2233-2235
pubmed: 32270178
Int J Infect Dis. 2020 Aug;97:7-10
pubmed: 32479865
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
BMJ. 2020 Sep 4;370:m3379
pubmed: 32887691
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Pharmacol Res. 2020 Jul;157:104826
pubmed: 32325127
AIDS Behav. 2010 Aug;14(4):824-35
pubmed: 18777131
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Infect Dis. 2015 Jul;15(7):810-8
pubmed: 26070969
Ann Intern Med. 2020 Oct 20;173(8):623-631
pubmed: 32673060
JAMA Intern Med. 2021 Jan 1;181(1):24-31
pubmed: 33080005
J Infect. 2020 Jul;81(1):e13-e20
pubmed: 32283144
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Int J Infect Dis. 2020 Aug;97:396-403
pubmed: 32623082
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):265-75
pubmed: 21471820
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
Arthritis Rheum. 2003 Jan;48(1):35-45
pubmed: 12528101
N Engl J Med. 2020 Sep 3;383(10):994
pubmed: 32649078
J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3
pubmed: 32470486
Front Immunol. 2020 May 15;11:1061
pubmed: 32574262
Lancet HIV. 2020 Aug;7(8):e554-e564
pubmed: 32473657
AIDS. 2020 Jul 1;34(8):1255-1256
pubmed: 32501850
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Lancet HIV. 2020 Jun;7(6):e383-e384
pubmed: 32416770
mBio. 2020 May 22;11(3):
pubmed: 32444382
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Clin Infect Dis. 2020 Nov 19;71(16):2294-2297
pubmed: 32472138
Sci Rep. 2017 Mar 06;7:43395
pubmed: 28262699
Clin Infect Dis. 2020 Nov 19;71(16):2199-2206
pubmed: 32407459
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Lancet HIV. 2021 Jan;8(1):e24-e32
pubmed: 33316211
Front Pharmacol. 2020 Aug 06;11:1196
pubmed: 32848795
Clin Infect Dis. 2020 Dec 31;71(11):2933-2938
pubmed: 32594164
Clin Infect Dis. 2020 Nov 19;71(16):2276-2278
pubmed: 32407467
Microorganisms. 2020 May 09;8(5):
pubmed: 32397399
J Thromb Thrombolysis. 2021 Apr;51(3):642-648
pubmed: 32809158
Clin Pharmacol Ther. 2017 Oct;102(4):591-598
pubmed: 28675418
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Drug Metab Dispos. 2007 Sep;35(9):1687-93
pubmed: 17576808
N Engl J Med. 2020 Nov 5;383(19):1827-1837
pubmed: 32459919
AIDS. 2018 Jan 28;32(3):277-292
pubmed: 29194119
J Am Soc Nephrol. 2020 Oct;31(10):2413-2423
pubmed: 32847984
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241
pubmed: 32671131
EBioMedicine. 2020 Nov;61:103026
pubmed: 33039714
Lancet HIV. 2020 May;7(5):e314-e316
pubmed: 32304642
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
J Immunol. 1999 Aug 1;163(3):1521-8
pubmed: 10415055
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32441299
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
AIDS Behav. 2021 Jan;25(1):85-92
pubmed: 32734438
Clin Infect Dis. 2011 Dec;53(11):1120-6
pubmed: 21998278
J Biol Chem. 2020 Oct 9;295(41):13958-13964
pubmed: 32587093
Infection. 2020 Oct;48(5):681-686
pubmed: 32394344
J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):6-10
pubmed: 32568770
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):368-75
pubmed: 22240460
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31821443
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Intern Emerg Med. 2020 Nov;15(8):1501-1506
pubmed: 32997237
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
N Engl J Med. 2020 Dec 10;383(24):2333-2344
pubmed: 33085857
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
J Med Virol. 2020 Jun;92(6):556-563
pubmed: 32104907
Nat Commun. 2020 Oct 15;11(1):5214
pubmed: 33060595
Microb Pathog. 2020 Aug;145:104228
pubmed: 32344177
Life Sci. 2020 Jul 15;253:117592
pubmed: 32222463
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
J Infect Dis. 2020 Aug 4;222(5):722-725
pubmed: 32559285
Nat Rev Clin Oncol. 2009 Aug;6(8):465-77
pubmed: 19581909
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
J Infect. 2020 Jul;81(1):e61-e66
pubmed: 32335173
Clin Infect Dis. 2021 Dec 6;73(11):e4073-e4081
pubmed: 32674126
J Med Virol. 2020 Jun;92(6):529-530
pubmed: 32160316
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Emerg Infect Dis. 2013 Nov;19(11):1766-74
pubmed: 24209781
J Pathol. 2008 Jan;214(2):231-41
pubmed: 18161758
J Thromb Thrombolysis. 2021 May;51(4):1107-1110
pubmed: 32246317
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Infect Dis. 2020 Dec;101:283-289
pubmed: 33007454
EBioMedicine. 2020 Aug;58:102887
pubmed: 32736307
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32430428
Front Immunol. 2018 Mar 13;9:302
pubmed: 29593707
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
JCI Insight. 2020 Dec 3;5(23):
pubmed: 33090972
J Antibiot (Tokyo). 2019 Oct;72(10):759-768
pubmed: 31300721
PLoS Med. 2020 Sep 3;17(9):e1003252
pubmed: 32881895
Clin Infect Dis. 2020 Nov 5;71(8):2021-2022
pubmed: 32459833
Ann Rheum Dis. 2020 Oct;79(10):1277-1285
pubmed: 32620597
JAMA Intern Med. 2021 Jan 1;181(1):32-40
pubmed: 33080017
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):971-978
pubmed: 32610262
PLoS One. 2013;8(3):e58812
pubmed: 23554932
J Infect. 2020 Aug;81(2):318-356
pubmed: 32333918
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Epidemiology. 2020 Nov;31(6):e49-e51
pubmed: 32773469
Nature. 2020 Sep;585(7826):588-590
pubmed: 32698190
ESMO Open. 2020 Sep;5(5):e000947
pubmed: 32978251
J Med Virol. 2020 Nov;92(11):2288-2290
pubmed: 32347975
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26955-26965
pubmed: 33037151
Front Med (Lausanne). 2020 Aug 25;7:557
pubmed: 32984388
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Open Forum Infect Dis. 2020 Sep 25;7(11):ofaa455
pubmed: 33200081
N Engl J Med. 2020 Nov 19;383(21):2041-2052
pubmed: 32706953
Semin Immunol. 2019 Jun;43:101300
pubmed: 31771760
Open Forum Infect Dis. 2020 Jun 05;7(7):ofaa219
pubmed: 32691007
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Int J Infect Dis. 2020 Dec;101:342-345
pubmed: 33039609
Med Mal Infect. 2020 Aug;50(5):397-400
pubmed: 32387320
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Clin Microbiol Infect. 2021 Feb;27(2):238-243
pubmed: 32979572
Circulation. 2020 Jul 21;142(3):303-305
pubmed: 32442023
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342
pubmed: 32202240
Ann Intern Med. 2020 Oct 6;173(7):536-541
pubmed: 32589451
Lancet Rheumatol. 2020 Jun;2(6):e325-e331
pubmed: 32501454
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32661006

Auteurs

María Del Mar Gutierrez (MDM)

Infectious Diseases Unit. Hospital De La Santa Creu I Sant Pau, Institut De Recerca Del Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.

Isabel Mur (I)

Infectious Diseases Unit. Hospital De La Santa Creu I Sant Pau, Institut De Recerca Del Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.

María Gracia Mateo (MG)

Infectious Diseases Unit. Hospital De La Santa Creu I Sant Pau, Institut De Recerca Del Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.

Francesc Vidal (F)

Infectious Diseases Unit. Hospital Universitari Joan XXIII, Universitat Rovira I Virgili, Tarragona, Spain.

Pere Domingo (P)

Infectious Diseases Unit. Hospital De La Santa Creu I Sant Pau, Institut De Recerca Del Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH